Health Trials

Non-Small Cell Lung Cancer (NSCLC, Locally Advanced or Metastatic, Second-line

1

Review clinical trials related to Non-Small Cell Lung Cancer (NSCLC, Locally Advanced or Metastatic, Second-line. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

The Study Of Andamertinib Plus Anlotinib In Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

This study is a single arm study to access the anti-tumor efficacy and safety of Andamertinib plus Anlotinib in patients with locally advanced or metastatic non-small cell lung cancer previously treated with third-generation EGFR-TKI.

Participants needed: 34
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Fudan UniversityUpdated: Aug 21, 2026Locations: 1
Eligibility criteria

Able to understand and voluntarily sign the written informed consent form. [+5]

Diagnosis of other malignant diseases within 3 years prior to first study drug a... [+9]

Read more